Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Yeah their website is still running and if you use their provided contact info it goes to Regen. Why not have an additional source of leads for your other company
I have no idea on this, maybe someone else knows.
What about his second filing?, never got the full story on that one, is his patent with the new company or did he give it to financier???
always that's all there is right now with this one! lol
AND THAT THE GOOD DOCTORS PATENT WAS THE KEY TO USING FAT CELLUlAR STEM CELL THERAPY!!!
Based on taht SVFC website still running? All IMO
What's that based on? I doubt this company ever files again, much less does anything that will benefit anyone
Keep the faith boys!!!
Looks like SVFC might run out of the trips after filings from the company? All IMO
In hind sight this dude is so shistey. Victor dermatology offers treatment through Regen who licensed it through intellicell who transferred the patents to Stromacell. It's highly likely this company is just a shell at this point. Essentially every facet of his web of companies is benefitting from this technology, except intellicell....
Ha!! The volume is BACK probably because them Camel Toes getting mixed up with "IT" and them clowns!! LOL!! Go SVFC!!!
Since no one was able to view my photo bucket link I posted of the press release via Scottrade a month or so ago....
"Factset research systems"
List of up top 50 shareholders for Intellicell Biosciences
"Boston Private Wealth LLC" 17,600 changed
Info as of June 30th 2017. This was the only company listed. Anyone wanting to see the original screen shot of the Scottrade press release I can email it.
Jon
Now its at 1.1 million volume up back to .0001!? What is going on?
well isn't that just awesome! LOL
Intellicell biosciences is marked "permanently closed" per google search
OH AND THERE IS 3,000 VOLUME????
Its so not understanding I cant even comment on why, what, how or where! My account still shows like everything is ok other than the price being basically nothing! Why delist and then it comes back??
I totally agree, something needs to happen!
Not sure how this is still listed when it was suspended for no filings..... and still has no filings. Unless Svfc contacted them privately?
I hope the slimy scumbag gets some fraud charges, SEC can't let scams like this get away with it!
Yeah that's for sure, if there is even anything left. Most places look like the pacific islands after WWII completely shredded. So much for paradise. A few years ago when I was mad at him on how he was handling things I said what goes around comes around and you will get what you deserve one day. I really hope he is ok and all his cronies, its totally devastating!
I have no idea what island he was on so it could have totally missed it but a good amount of them got hammered.
Darn it!! I was just about to snort some fresh crushed dried out/rotten CamelToes nails up my nose to give me an instant heart attack, but figured I live another day in case someone has another CamelToe joke/comment! Ha!
It will keep he and his SHORTING CREW busy for a while!!!
Come on TURBO he's fixing cameltoes for those rich SHAKES, MONEY, MONEY, MONEY in the future for us share holders!!!
I wonder if the BIG BAD Wolf and his crew got their homes blown away in the Caribbean?!
Vic is out in Dubai again. Life seems peachy for the Regen crew, despite shareholders misfortunes.
Darn good question! This is the most fishy stock I have seen!
Ihub only showes 1.6 billion shares in issue, I wonder where the 200 billion original shares went???
Over a million in volume today?? WHAT??!!
Google worthless stocks. I was referring to the US only.
I don't know that you can actually take the loss without selling the stock, this just seems like an easy way out.
If the stock is deemed worthless, you can take the loss on your tax returns without selling it. IMO
This is the first stock that actually stopped trading before I could sell and take the loss.
I sent an email letter to E*TRADE requesting them to research the stock SVFC. I told them I had reason to believe that the stock had been delisted. Within 24 hours they responded letting me know that SVFC was no longer trading and considered worthless securities. They then offered to buy my worthless securities all of them for one penny. At least this will allow me to get a 1099 showing all my losses and the fee was five dollars.
Ahh, got it sorry about that. I have lost my total investment here as well.
GLTY
L6
They are not getting my shares for a total of .01. F that.
Whatever ...I plan to describe my experience with Vic.....my personal experience of his lying to my face about the product ...every chance I get . I can handle my losses, but we all know what he did.
I wish this stock would have hit a penny.
You misunderstand my post they bought all my worthless securities for one penny not each share.
If you would like to see the email correspondence between myself and E*TRADE contact me at the following email address:
jblondin_2@yahoo.com
Who is they? What brokerage?
I just got a completion notice of my worthless securities removal notice and they have been delisted. They bought all my worthless securities for $0.01. Now I can at least write off my losses.
Yeah couldn't tell ya why theirs volume. All guesses at this point.
Why is the volume and who did it?? I'm so confused with this one I don't know what's going on as most don't either.
I found my remote control and clicked off the "mute" button......suddenly I got some volume today, cool!! SVFC!!!
Funny I was just on my Schwab account and the account has been relisted! It was showing N/A and zero $. Now its back on showing .0001 and the value with the amount of shares I have. What in the world is going on? I thought this was taken down?
Followers
|
401
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
91007
|
Created
|
09/01/03
|
Type
|
Free
|
Moderators |
OTC Pnk
SHARE STRUCTURE:
Authorized Shares
250,000,000,000
SHARES OUTSTANDING:
7,894,037,082
issued and outstanding as of November 19, 2014
an increase of 4,238,984,241
from the below
3,655,052,841
as of October 9, 2014
AUTHORIZED SHARES:
250,000,000,000
Common Stock from Ten Billion (10,000,000,000) shares of Common Stock to Two Hundred Fifty Billion (250,000,000,000) shares of Common Stock and (b) the Company’s preferred stock, par value $0.01 per share, from One Million (1,000,000) shares of preferred stock to Twenty-Five Million (25,000,000) shares of preferred stock
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10401892
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10244545
an increase of 1,299,077,468 between the above & below link
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10056697
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10094756
1) Holders of some of our promissory notes which are now in default could, if they were to successfully enforce those notes in a law suit, levy on our assets and have them sold to satisfy our obligations on the notes.
2) Part of our debt held by promissory note holders has been assumed by Redwood Management, LLC. However, our bridge notes and our convertible promissory notes held by some of our promissory note holders are in default, and we are not in a position to repay them. We intend to use the proceeds of a future offering to pay off such notes. Holders of those notes could if they choose to sue on those notes, and if they were successful in their lawsuits they could levy on our assets and have those assets sold to satisfy the amounts we owe them.
3) As of May 9, 2014, we had 228 holders of record of our common stock and 2,230,314,377 shares of common stock issued and
outstanding.
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9979496
I will gladly let the investing public decide as
during this time Victor & Anna sold $1.5M worth of notes/shares this was also happening
Quote:
TOTAL STOCKHOLDERS' DEFICIT (21,167,614) March 31, 2014 (9,849,067) December 31, 2013
Quote:
NET LOSS $ (13,004,773) $ (1,058,459)
Quote:
Number of shares of common stock issued and outstanding as of June 18, 2014 is 2,355,075,373.
Quote:
Accumulated deficit (61,908,223) March 31, 2014 (48,903,450) December 31, 2013
Quote:
Number of shares of common stock issued and outstanding as of June 18, 2014 is 2,355,075,373.
Quote:
The number of outstanding shares of the Registrant’s Common Stock, $0.0001 par value, at May 9, 2014 was 2,230,314,377.
Quote:
Dominion Capital Debenture
On March 24, 2014, Ironridge Global sold the TCA Note to Dominion Capital under the security settlement agreement executed between the Company and Dominion Capital, and the Company issued a convertible debenture to Dominion Capital in the amount of $746,092 (the “Dominion Debenture”). The $746,092 principal balance included the original TCA Note of $500,000, accrued interest and pre-payment penalties of $246,092.
The Dominion Capital Debenture matures on March 24, 2015 and accrues interest at an annual rate equal to 7.5%. At any time, and at its sole option, Dominion Capital can to convert a portion or all amounts of principal and interest due and outstanding under the Dominion Debenture into shares of common stock at a price equal to 48.5% of the average of the three lowest prices per share of reported trades (not on the same day) of the common stock on the OTC Markets or on the exchange which the common stock is then listed as quoted by Bloomberg, LP during the 20 trading days preceding the conversion date.
As of March 31, 2014, the Dominion Debenture had a principal balance of $746,092, and accrued interest of $1,088.
Quote:was only Victor & Anna were cashing in over $1.5M while also causing 31,720,856 shares to enter the market FACT
Part of our debt held by promissory note holders has been assumed by Redwood Management, LLC.
the above was installed & can only be removed or edited by BigBadWolf & NO data/info may be placed above it as per admin Ms. Linda's private message to ALL MOD's
Publication in The American Journal ofMedicine showing regenerative results of cardiac function with SVFC's patented technology
INTELLICELL BIOSCIENCES, INC.
About IntelliCell BioSciences, Inc.
IntelliCell™ is pioneering a new proprietary medical process that results in acquiring Vascular Fraction Cells (VFC). VFC is also known as stromal vascular fraction. VFC cells are known to contain significant numbers of various cell types including adult stem cells, endothelial cells, fibroblast cells, red blood cells, and much more. VFC type cells are in research projects and in clinical trials around the world.
IntelliCell was formed to take a leading role and harmonize the interests of all the stakeholder communities in the rapidly expanding regenerative medicine field. IntelliCell is fully committed to an ethical and supportive role in providing the tools to physicians and patients to fight some of the most serious disease conditions with very high levels of unmet clinical needs.
The VFC cells that are being processed by IntelliCell are known as autologous cells. That is the donor of cells and the recipient of the cells are the same person. IntelliCell is unique as it does not use any chemicals or biological agents such as collagenese in its proprietary and patent pending process. The Company has developed a novel ultrasound process to assist the laboratory in the preparation of the VFC cells. In a process similar to the acquisition of autologous stem cells from bone marrow aspirate, the IntelliCell VFC cells are being given to physicians working in the field of regenerative medicine.
LATEST SHAREHOLDER LETTER
NEW YORK, NY--(Marketwired - Dec 10, 2013) - IntelliCell Biosciences, Inc. (OTCQB: SVFC), a regenerative medicine company utilizing adult autologous vascular cells (SVCs) derived from the blood vessels found in adipose tissue, provides shareholder update.
Dear Valued Shareholders,
On behalf of myself, the Board of Directors and the entire IntelliCell team, I would like to let you know that we are pleased with the growth initiatives that we have accomplished since our initial shareholder letter.
Now is an important and exciting time for IntelliCell Biosciences. We have continued to improve our competitive position in the regenerative medicine field and I believe we have never been stronger or better positioned for future growth. The worldwide regenerative medicine market is being driven by previously unseen treatments and procedures that are improving the quality of life of patients around the world and we firmly believe that we will emerge as one of the leaders in this industry.
The Company has been executing on our strategic plan and business priorities this year. We have made advancements in our technology and have filed patents around the world for our proprietary regenerative medical solutions. I am encouraged by the expanding market presence of IntelliCell Biosciences and the escalating acceptance of the Company's products and solutions within the medical, scientific and investment community. Additionally, we continue to work hard at improving our balance sheet and financial position, in order to have the necessary resources to take advantage of our growth opportunities. Because of all these accomplishments, I believe we are better positioned than ever for growth.
We have focused primarily on three strategic initiatives, Growth, Leverage, and Financial Strength, in order to improve the overall standing of the company.
Growth: We will continue to grow and supply our cellular product to physicians to treat their patients with clinical needs. We intend to be a major provider of minimally manipulated stromal vascular fraction cells SVFCs for autologous use to physicians and achieve exciting clinical results that improve the quality of life for their patients.
Leverage: We are leveraging our scale and best practices to create a cost-effect business model that increases our competitive advantage over our industry peers. Our intent is to open 3 additional facilities in 3 states in the next 12 months. Once the model is perfected, we will roll out additional facilities at a more aggressive pace. As the regenerative medical market expands, we intend to be the most recognized name in the industry.
Financial Strength: We have a goal of improving our balance sheet and income statement in order to deliver strong shareholder returns. Currently we are enacting a plan to remove all debt from our balance sheet. Going forward, it is our intent to use equity capital for the advancement of our company. Believing that IntelliCell Biosciences stock is undervalued, I will be converting a portion of my debt into shares and will continue this practice going forward. These measures will enable us to continue implementing our business and open new Cellular Labs in hospitals and ambulatory surgical centers that will significantly increase our revenues.
We are committed to advance the regenerative medicine field. This will enable us to become more productive, reliable and cost effective than ever before. IntelliCell's physician partners have informed us that we are well-aligned with their strategic intentions, and their clinical and business priorities. These are the key priorities that will ensure IntelliCell's future success.
As many of you know, our technology is new and cutting edge and requires acceptance by the marketplace and the regulators. We will remain aggressive in our efforts to overcome industry obstacles so that our medical solutions can serve as the industry standard. The Company has successfully developed advanced medical technologies, most notably its patented process of isolating SVFCs from adipose (fat) tissue using a mechanical technique, exclusive to the industry of regenerative medicine, now being used by physicians to treat patients with previously unmet clinical needs.
Management firmly believes that regenerative medicine is the future of medicine and we intend to aggressively expand our market footprint in order to solidify our position as the leader in the field. We would like to express our gratitude to our loyal global customer base and we are grateful to our shareholders for their continued support and ownership in our company. As CEO and Founder of IntelliCell, my paramount responsibility is to enhance shareholder value. I take immense pride in the success of this company to date and remain committed to delivering the best products and services possible to increase market presence in the future.
We at IntelliCell Biosciences are confident that our vision and goals will be achieved.
Sincerely,
Dr. Steven Victor
Chief Executive Officer
IntelliCell Biosciences, Inc.
Link to the most recent FDA Inspection Form 483 issued on 06/06/2013 http://www.ipscell.com/wp-content/uploads/2013/08/Intellicell-483_2013.pdf
RELEVANT LINKS
DD COMPILATION (January 30, 2014)
http://www.intellicellbiosciences.com
https://twitter.com/stevenvictormd
DAILY CHART
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |